高级检索
当前位置: 首页 > 详情页

Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究参与人:
研究单位: [1]Guangzhou University of Traditional Chinese Medicine [2]Guangdong Provincial Hospital of Chinese Medicine Guangzhou,Guangdong,China,510120 [3]Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University Guangzhou,Guangdong,China,510120 [4]Guangzhou Hospital of Integrated traditional and west medicine Guangzhou,Guangdong,China,510800 [5]Panyu Hospital of Chinese Medicine Guangzhou,Guangdong,China,511400 [6]Boluo County People's Hospital Huizhou,Guangdong,China,514610 [7]Jiangmen Wuyi Traditional Chinese Medicine Hospital Jiangmen,Guangdong,China,529000 [8]Lianjiang People's hospital Lianjiang,Guangdong,China,524400 [9]Yangjiang Hospital of Traditional Chinese Medicine Yangjiang,Guangdong,China,529500 [10]Zengcheng City Hospital of traditional Chinese Medicine Zengcheng,Guangdong,China,510000 [11]Boji-affiliated Hospital of Sun Yat-sen University Zengcheng,Guangdong,China,511300

研究目的:
In order to investigate the time window of acute intracerebral hemorrhage(AICH) by "Blood Activating and Stasis Dispersing" therapy and to verify traditional methods if it would influence or enlarge the brain hematoma, test is made by random double-blind controlled. Patients are classified to (0-6h)and (6-72h) teams. Herbs is separated too. The period of the therapy lasts two weeks, and the follow up should last three months. The main indexes are mortality rate, disability rate and the brain hematoma situation. The review is made by the reference to (NIHSS),(GCS) and so on. So, the window time is determined through this test.

资源点击量:2020 今日访问量:0 总访问量:646 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号